Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDQ.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XDQ.2NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
XDQ.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XDQ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDQ.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XDQ.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XDQ.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDQ.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
XDQ.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XDQ.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XDQ.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
XDQ.2NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
XDQ.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDQ.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDQ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDQ.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
HV.1.11NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
HV.1.11NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
HV.1.11NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
HV.1.11NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
HV.1.11NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HV.1.11NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
HV.1.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HV.1.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HV.1.11NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
HV.1.11NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
HV.1.11NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
HV.1.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.11NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
HV.1.11NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
HV.1.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HV.1.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HV.1.11NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
HV.1.11NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
HV.1.11NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
HV.1.11NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
HV.1.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HV.1.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HV.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.11NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KA.1NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
KA.1NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
KA.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
KA.1NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
KA.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
KA.1NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
KA.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KA.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KA.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
KA.1NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used